The company aims to start a pivotal trial this year, file for 510(k) clearance in 2027 and launch the device in 2028.

Led by researchers at NDORMS as part of the Data Analysis and Real World Interrogation Network (DARWIN EU) initiative, a new ...

TenoMiR to Progress to Phase 3 Study for Lateral Epicondylitis, Making it One of the Most Advanced microRNA Clinical Programs GLASGOW, Scotland, March 19, 2026 (GLOBE NEWSWIRE) -- Causeway ...

Several experimental prostate cancer drugs have produced striking results in early-stage clinical trials, with at least one ...

ClinCapture announces AI-powered clinical trial build tech that automates study configuration, and advances intelligent ...

BlueRock Therapeutics, a Bayer subsidiary developing stem cell treatments for Parkinson’s disease, has partnered with Rune ...

Managing non-EDC (Electronic Data Capture) data integration in clinical trials is a challenge that holds significant promise. As clinical studies continue to draw on data from wearable devices like ...

The first experimental use of chemotherapy was conducted in 1942 using nitrogen mustard to treat non-Hodgkin lymphoma, 1,2 marking the beginning of modern chemotherapy development, the transition from ...

NEW YORK--(BUSINESS WIRE)--Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced the launch of Medidata Clinical Data ...

A powerful new real-world data platform could transform how scientists predict and understand Alzheimer's disease and ...